Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-'

S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-'

MT newswireMT newswire2026/09/04 17:02
01:02 PM EDT, 09/04/2026 (MT Newswires) -- S&P Global Ratings (SPGI) said Friday it raised its rating on Teva Pharmaceutical (TEVA), including its issuer credit rating and issue-level rating on the company's unsecured debt, to 'BBB-' from 'BB+'. Teva has demonstrated sustainable growth prospects through strong execution in branded products, stabilization in generics, and a pipeline of significant late-stage assets, supporting S&P Global Ratings' view of its earnings durability, at least over the next two years, S&P Global said.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs predicts Anthropic's annual revenue will soar to $685 billion by 2030, supporting a $1.4 trillion IPO valuation

According to insiders, the Goldman Sachs research team expects that the annual revenue of the AI startup Anthropic will soar to approximately 685 billions USD by 2030, nearly 150 times higher than the forecasted 4.59 billions USD in 2025.

智通财经•2026/11/10 16:23